Endoplasmic-Reticulum Stress Pathway-Associated Mechanisms of Action of Proteasome Inhibitors in Multiple Myeloma

International Journal of Hematology - Japan
doi 10.1007/s12185-016-2016-0
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2014English

Proteasome Inhibitor Lactacystin Enhances Cisplatin Cytotoxicity by Increasing Endoplasmic Reticulum Stress-Associated Apoptosis in HeLa Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Proteasome Inhibitors Block Ikaros Degradation by Lenalidomide in Multiple Myeloma

Haematologica
Hematology
2015English

MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Novel Strategies in the Treatment of Multiple Myeloma: From Proteasome Inhibitors to Immunotherapy

Journal of Cell Science & Therapy
2010English

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Endoplasmic Reticulum Stress Response

2011English

Endoplasmic Reticulum Stress Response

2011English

Molecular Components of a Cell Death Pathway Activated by Endoplasmic Reticulum Stress

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy